Works matching IS 1742464X AND DT 2021 AND VI 288 AND IP 17

Results: 17

Spotlight on COVID‐19: eighteen months on.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 4992, doi. 10.1111/febs.16167

By:

Zacchigna, Serena;
Marcello, Alessandro;
Banks, Lawrence

Publication type:

Article

Protons to Patients: targeting endosomal Na<sup>+</sup>/H<sup>+</sup> exchangers against COVID‐19 and other viral diseases.

Published in:: FEBS Journal, 2021, v. 288, n. 17, p. 5071, doi. 10.1111/febs.16163
Publication type:: Article

Overview of antiviral drug candidates targeting coronaviral 3C‐like main proteases.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5089, doi. 10.1111/febs.15696

By:

Chen, Chun‐Chi;
Yu, Xuejing;
Kuo, Chih‐Jung;
Min, Jian;
Chen, Sizhuo;
Ma, Lixin;
Liu, Ke;
Guo, Rey‐Ting

Publication type:

Article

Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID‐19 patients.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5190, doi. 10.1111/febs.15609

By:

Zeng, Hao‐Long;
Chen, Di;
Yan, Jingjun;
Yang, Qing;
Han, Qiang‐Qiang;
Li, Shu‐Sheng;
Cheng, Liming

Publication type:

Article

The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5042, doi. 10.1111/febs.16105

By:

Tong, Zhen Wei Marcus;
Grant, Emma;
Gras, Stephanie;
Wu, Melanie;
Smith, Corey;
Barrett, Helen L.;
Gallo, Linda A.;
Short, Kirsty R.

Publication type:

Article

Identification of a special cell type as a determinant of the kidney tropism of SARS‐CoV‐2.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5163, doi. 10.1111/febs.16114

By:

Lin, Hongchun;
Ma, Xinxin;
Xiao, Fang;
Su, Hua;
Shi, Yaling;
Liu, Yuntao;
Song, Lan;
Zhang, Zhongde;
Zhang, Chun;
Peng, Hui

Publication type:

Article

Targeting neuropilins as a viable SARS‐CoV‐2 treatment.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5122, doi. 10.1111/febs.16096

By:

Sarabipour, Sarvenaz;
Mac Gabhann, Feilim

Publication type:

Article

COVID‐19 vaccines: what do we know so far?

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 4996, doi. 10.1111/febs.16094

By:

Dhillon, Paraminder;
Altmann, Daniel;
Male, Victoria

Publication type:

Article

Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5021, doi. 10.1111/febs.15961

By:

Ku, Cheng‐Lung;
Chen, I‐Ting;
Lai, Ming‐Zong

Publication type:

Article

Host PDZ‐containing proteins targeted by SARS‐CoV‐2.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5148, doi. 10.1111/febs.15881

By:

Caillet‐Saguy, Célia;
Durbesson, Fabien;
Rezelj, Veronica V.;
Gogl, Gergö;
Tran, Quang Dinh;
Twizere, Jean‐Claude;
Vignuzzi, Marco;
Vincentelli, Renaud;
Wolff, Nicolas

Publication type:

Article

Non‐optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5201, doi. 10.1111/febs.15835

By:

Carmi, Gon;
Gorohovski, Alessandro;
Mukherjee, Sumit;
Frenkel‐Morgenstern, Milana

Publication type:

Article

New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'‐5' exoribonucleolytic activity on SARS‐CoV‐2.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5130, doi. 10.1111/febs.15815

By:

Saramago, Margarida;
Bárria, Cátia;
Costa, Vanessa G.;
Souza, Caio S.;
Viegas, Sandra C.;
Domingues, Susana;
Lousa, Diana;
Soares, Cláudio M.;
Arraiano, Cecília M.;
Matos, Rute G.

Publication type:

Article

The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5179, doi. 10.1111/febs.15784

By:

Merzon, Eugene;
Green, Ilan;
Vinker, Shlomo;
Golan‐Cohen, Avivit;
Gorohovski, Alessandro;
Avramovich, Eva;
Frenkel‐Morgenstern, Milana;
Magen, Eli

Publication type:

Article

Table of Contents.

Published in:: FEBS Journal, 2021, v. 288, n. 17, p. 5224, doi. 10.1111/febs.15409
Publication type:: Article

The structural basis of accelerated host cell entry by SARS‐CoV‐2†.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5010, doi. 10.1111/febs.15651

By:

Seyran, Murat;
Takayama, Kazuo;
Uversky, Vladimir N.;
Lundstrom, Kenneth;
Palù, Giorgio;
Sherchan, Samendra P.;
Attrish, Diksha;
Rezaei, Nima;
Aljabali, Alaa A. A.;
Ghosh, Shinjini;
Pizzol, Damiano;
Chauhan, Gaurav;
Adadi, Parise;
Mohamed Abd El‐Aziz, Tarek;
Soares, Antonio G.;
Kandimalla, Ramesh;
Tambuwala, Murtaza;
Hassan, Sk. Sarif;
Azad, Gajendra Kumar;
Pal Choudhury, Pabitra

Publication type:

Article

The effects of aging on host resistance and disease tolerance to SARS‐CoV‐2 infection.

Published in:

FEBS Journal, 2021, v. 288, n. 17, p. 5055, doi. 10.1111/febs.15613

By:

Mok, Darren Z. L.;
Chan, Candice Yuen Yue;
Ooi, Eng Eong;
Chan, Kuan Rong

Publication type:

Article

Issue Information.

Published in:: FEBS Journal, 2021, v. 288, n. 17, p. 4989, doi. 10.1111/febs.15408
Publication type:: Article